Your browser doesn't support javascript.
loading
Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
Pasvolsky, Oren; Saliba, Rima M; Masood, Adeel; Mohamedi, Ali H; Tanner, Mark R; Bashir, Qaiser; Srour, Samer; Saini, Neeraj; Ramdial, Jeremy; Nieto, Yago; Lee, Hans C; Patel, Krina K; Kebriaei, Partow; Thomas, Sheeba K; Weber, Donna M; Orlowski, Robert Z; Shpall, Elizabeth J; Champlin, Richard E; Qazilbash, Muzaffar H.
Afiliação
  • Pasvolsky O; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Saliba RM; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.
  • Masood A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Mohamedi AH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Tanner MR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Srour S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Saini N; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Ramdial J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Lee HC; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Patel KK; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Kebriaei P; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Thomas SK; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Weber DM; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Shpall EJ; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Champlin RE; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Br J Haematol ; 201(4): e37-e41, 2023 05.
Article em En | MEDLINE | ID: mdl-36916461
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos